Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial
PaperCitations, authors & open-access status
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 103 citations, 2020 year and gold oa status.
103
Citations
2020
Year
gold
OA Status